Skip to main content
. 2020 Apr 3;10:431. doi: 10.3389/fonc.2020.00431

Table 1.

Basic clinicopathological characteristics of BCBM patients.

Clinicopathological features No. (%)
Age at initial diagnosis
<40 57 (26.5)
40–59 141 (65.6)
≥60 17 (7.9)
TNM stage
I 8 (3.7)
II 55 (25.6)
III 71 (33.0)
IV 42 (19.5)
Unknown 39 (18.1)
Pathology type
Ductal 192 (89.3)
Lobular 6 (2.8)
Other 7 (3.3)
Unknown 10 (4.7)
Histological grade
I 0 (0)
II 49 (22.8)
III 47 (21.9)
Unknown 119 (55.3)
Molecular subtypes
Luminal (HER-) 75 (34.9)
HER2+ 88 (40.9)
Triple negative 51 (23.7)
Unknown 1 (0.5)
Bone metastasis
No 121 (56.3)
Yes 93 (43.3)
Unknown 1 (0.5)
Liver metastases
No 135 (62.8)
Yes 78 (36.3)
Unknown 2 (0.9)
Lung metastasis
No 108 (50.2)
Yes 107 (49.8)
Number of brain metastasis
Single 41 (19.1)
Multiple 148 (68.8)
Unknown 26 (12.1)
Surgical resection of brain tumor
Yes 42 (20)
No 172 (80)
Whole brain radiotherapy
Yes 122 (56.7)
No 93 (43.3)
Stereotactic surgery
Yes 54 (74.9)
No 161 (25.1)